Skip to main content

March 2022

 

 

academics

 

Clinical research courses

Pharma Faculty Recruitment at Dadasaheb Balpande College Pharmacy

Ambe Durga Education Society was established in the year 1997. The trust got registration certificate under society’s registration act 1860 and Bombay Public Act 1950. The registration numbers are MAH-663/1997 and F-14563 respectively. ADES has been constituted by great visionary Hon’ble Shri Vitthalrao alias Dadasaheb Balpande with vision to provide basic and higher education to socially and economically backward communities. To achieve this noble goal, ADES has started Dadasaheb Balpande College of Pharmacy (DBCOP), in the year 2006 offering B.Pharm.

Pharma Faculty Recruitment at Assam Don Bosco University

Don Bosco University is a project of the Salesians of Don Bosco (SDB) executed by Don Bosco Society, Azara, Guwahati. Presently, Salesians are working in 132 countries catering to over nine million young people worldwide; Salesians have been recognized by Government of India as the single largest provider of technical education in India, second only to the Government.

Assam Don Bosco University invites applications for the following posts mentioned below.

Walk in interview for M.Pharm, M.Sc, B.Pharm in Production & Packing at MSN Laboratories Pvt. Ltd

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar.

Production & Packing (OSD ) Dept - Formulation Division

Post : Officer | Jr. Executive | Executive | Sr. Executive

Walk in interview for M.Pharm, M.Sc, B.Pharm in QA, QC at Synergene Active Ingredients Pvt. Ltd

Synergene Active Ingredients Pvt. Ltd., incorporated in 2006, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic categories. The therapeutic segments of focus are Anti-Fungal, Anti-Depressant, Anti-Migraine. Anti-Glaucoma, Anti-Hypertensive, Analgesic, Anti-Histaminic, Antibiotic, Premature Ejaculation and Nootropic.

Walk in interview for M.Sc, B.Pharm in Production, QA, QC at SMS Pharma

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.

Natural COVID-19 antibodies lasts seven months for children : Study

Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.

The study was published today in Pediatrics.
Researchers examined data from 218 children across the state of Texas between the ages of 5 and 19 who were enrolled in the Texas CARES survey, which began in October of 2020 with the goal of assessing COVID-19 antibody status over time among a population of adults and children in Texas.

Effectiveness of antibiotics significantly reduced when multiple bugs present

A study has found that much higher doses of antibiotics are needed to eliminate a bacterial infection of the airways when other microbes are present. It helps explain why respiratory infections often persist in people with lung diseases such as cystic fibrosis despite treatment.

Bharat Biotech joined with Biofabri to develop and distribute novel TB vaccine

Bharat Biotech has entered into a partnership with Biofabri, a Spanish biopharmaceutical firm, for the development, manufacturing and marketing of a new tuberculosis vaccine. This partnership will guarantee the supply of TB vaccines in more than 70 countries especially in Southeast Asia, and sub-Saharan Africa with a high TB incidence.

New tech to aid screening and monitoring of lung diseases

India has a high burden of Tuberculosis, recording close to 2.64 million cases and 75,000 plus deaths in 2019. A considerable percentage of these cases come from underdeveloped, remote areas without proper access to healthcare services. It is a huge challenge to triage, screen, and monitor it promptly, and at scale, with minimal resources.

Granules India receives license to market Paxlovid of Pfizer

Granules India ltd has received a license from Medicines Patent Pool (MPP) to manufacture and market generic versions of Pfizer’s oral treatment nirmatrelvir which will be copackaged with ritonavir for treatment of COVID-19. The licenses are applicable for both active pharmaceutical ingredients (API) and finished products, in tablet form, of nirmatrelvir; ritonavir.